Showing results (121-130 of 300) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cellsLaura Rosanò, Roberta Cianfrocca, Francesca Spinella, et al.
Molecular Pharmacology|June 20, 2003
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistanceCristiano Ferlini, Giuseppina Raspaglio, Simona Mozzetti, et al.
Gynecologic Oncology|December 17, 2010
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1)Gabriella Macchia, Gabriella Ferrandina, Francesco Deodato, et al.
Menopause (New York, N.Y.)|August 27, 2015
Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancerPaola Villa, Anna P Lassandro, Inbal D Amar, et al.
Acta Oncologica (Stockholm, Sweden)|September 21, 2013
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparisonGabriella Macchia, Savino Cilla, Alessio Giuseppe Morganti, et al.
American Journal of Clinical Oncology|June 6, 2008
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation studyNuma Cellini, Daniela Smaniotto, Giovanni Scambia, et al.
Surgical Endoscopy|January 14, 2014
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experienceValerio Gallotta, Anna Fagotti, Francesco Fanfani, et al.
Journal of Minimally Invasive Gynecology|September 27, 2016
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II StudyValerio Gallotta, Vito Chiantera, Carmine Conte, et al.
Pageof 30